Details of the Drug
General Information of Drug (ID: DMFPUGV)
Drug Name |
1-(3-Phenylallylidene)thiosemicarbazide
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
Cinnamaldehyde thiosemicarbazone; CHEMBL388025; 5351-70-2; 1-(3-Phenylallylidene)thiosemicarbazide; AC1NVG31; Cinnamaldehydethiosemicarbazone; 3-Phenylpropenalthiosemicarbazone; BDBM50241213; ZINC11536050; 3-phenylacrylaldehyde thiosemicarbazone; AKOS023092594; (Z)-1-((E)-3-phenylallylidene)thiosemicarbazide; AF-960/00472016; [(Z)-[(E)-3-phenylprop-2-enylidene]amino]thiourea; F3111-2831; N'-[(3-phenylprop-2-en-1-ylidene)amino]carbamimidothioic acid; (1Z,N'Z)-N'-((E)-3-phenylallylidene)carbamohydrazonothioic acid
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 205.28 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 1.6 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 3 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 2 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||